跳到正文
TGA 实验室检测报告·AI 评分43

TGA 对单一活性成分维生素 D3 产品的检测报告

Testing of vitamin D3 in single active products

AI 导读

TGA 实验室对 2023 年 1 月至 12 月澳大利亚销量最高的 13 款单一成分维生素 D3 产品(来自 9 家申办方)开展质量调查,检测于 2024 年 4 月至 8 月由认可第三方实验室完成。所有受检产品均符合相关活性成分含量质量标准,含量结果介于标签声称值的 90.0%–158.3%。

正文 · 原文

Introduction and scope

Vitamin D plays an essential role in developing, functioning and maintaining healthy bones with severe deficiency causing rickets in children and osteomalacia in adults. People mainly get vitamin D through exposure to sunlight, specifically UVB rays, due to the minimal amounts of vitamin D in most foods (1). To address or prevent deficiencies, many people are guided to take vitamin D oral supplements (2).

The two main forms of vitamin D are ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3). Most products available in Australia contain vitamin D3 formulated into soft-gel capsules, tablets, effervescent tablets and liquids. However, vitamin D3 is sensitive to air, heat and light, which can affect its stability (3). Because of these known issues, and the importance of vitamin D3 to public health, the Therapeutic Goods Administration (TGA) Laboratories Branch conducted a quality survey of vitamin D3 products.

This survey focused on single-ingredient vitamin D3 products with high sales volumes in Australia between January and December 2023.[1] The TGA tested 13 of the top-selling products, which were supplied by nine different sponsors.

Testing

Samples

The Laboratories Branch purchased and received samples of listed products from online pharmacies and a registered product from a wholesaler pharmaceutical supplier. Details of the samples obtained for testing are outlined in Appendix A.

Requirements for compliance

For liquid products and the registered tablet product the sponsor’s specifications were applied.

For the remaining samples that were all tablets or capsules, the content limit 90.0 - 165.0% of label claim for oil-soluble vitamins as defined in Schedule 2 in the Therapeutic Goods (Standard for Tablets, Capsules and Pills) (TGO 101) Order 2019 was applied.

Content of vitamin D3

Capsules and tablets were sampled from the primary container, de-identified, packed in labelled containers and protected from light. Liquid samples remained in their primary container but were still de-identified and re-labelled.

The samples were tested for vitamin D3 content by an accredited third-party testing laboratory. Testing was conducted between April and August 2024. The results were recorded as micrograms per 100 grams and converted to percentage of the label claim before being assessed against the relevant requirements.

Results and conclusions

All of the vitamin D3 products tested met the relevant quality standard for active ingredient content. Detailed results for each sample are provided in Appendix A.

Overall, these findings show that the 13 highest-selling vitamin D3 products on the Australian market (January to December 2023) were compliant with TGA requirements for content of active ingredient. This confirms that these products contain appropriate levels of the active ingredient for consumer use.

References

  1. Engelsen, O. The Relationship between Ultraviolet Radiation Exposure and Vitamin D Status, Nutrients. 2010, 2(5), 482–495.
  2. National Health Institute, https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/, accessed March 2025
  3. Al-Hashimi, N.; Abraham, S. Cholecalciferol National Library of Medicine, StatPearls https://www.ncbi.nlm.nih.gov/books/NBK549768/

Appendix A: Details and results of samples analysed

ARTG NumberProduct NameBatch NumberExpiry DateSupplierLabel Claim IU/unit

Assay Result

% LC (TGO 101 requirement 90.0 – 165.0% unless otherwise specified)

199895Ostelin Vitamin D3 1000 IU164725730/09/2025Sanofi-Aventis Healthcare Pty Ltd T/A1000103.6
256292OsteVit-D One-A-Week colecalciferol 7000IU23G25E231/07/2025Key Pharmaceuticals Pty Ltd700090.0 
(Sponsor specification 90.0 – 110.0)
226248Ostelin Kids Vitamin D3 Liquid7692431/03/2025Sanofi-Aventis Healthcare Pty Ltd T/A200 IU / 0.5mL

103.8

(Sponsor’s specifications: 90.0 – 165.0)

218606Pharmacy Action Vitamin D3345331/08/2026Generic Health Pty Ltd1000153.4
231863Swisse Ultiboost Vitamin D9372930/09/2026Swisse Wellness Pty Ltd1000101.6
164567Vita-D Vitamin D Supplement11426031/05/2026Petrus Pharmaceuticals Pty Ltd1000150.2
297189Ostelin Infant Vitamin D3 drops76955B31/08/2024Sanofi-Aventis Healthcare Pty Ltd T/A400 IU / 0.03 mL

145.9

(Sponsor’s specifications: 90.0 – 165.0)

287327Wagner Vitamin D3 1000 IU2329931/05/2026RF Six Pty Ltd1000146.5
164261OsteVit-D ONE-A-DAY Vitamin D32270331/07/2025Key Pharmaceuticals Pty Ltd1000114.7
186719Blackmores Vitamin D3 1000IU31723319/01/2026Blackmores Ltd100098.3
237672Ostelin Vitamin D3 1000IU Liquid7974031/10/2026Sanofi-Aventis Healthcare Pty Ltd T/A1000 IU / 0.5 mL

126.3

(Sponsor’s specifications: 90.0 – 165.0)

196141Faulding Vitamin D 1000IU3441031/10/2024Symbion Pty Ltd1000158.3
160634Bioglan Vitamin D3 1000IU3464231/05/2025Natural Bio Pty Limited1000145.2

Footnote

  1. Based on data supplied by IQVIA to the TGA on Australian sales. Reported December 2023.

来源:TGA 实验室检测报告 · tga.gov.au